Literature DB >> 22040225

The neuroprotective effect of pyrroloquinoline quinone on traumatic brain injury.

Lili Zhang1, Jie Liu, Chun Cheng, Ying Yuan, Biyun Yu, Aiguo Shen, Meijuan Yan.   

Abstract

Pyrroloquinoline quinone (PQQ) is a water-soluble, anionic, quinonoid substance that has been established as an essential nutrient in animals. Owing to the inherent properties of PQQ as an antioxidant and redox modulator in various systems, PQQ is expected to be used in pharmacological applications in the near future. Although many recent studies have investigated its neuroprotective effects, the effect of PQQ on traumatic brain injury (TBI) has not been examined. In this study we employed Morris water maze (MWM) training, the results of which showed that PQQ led to improved behavioral performance in post-TBI animals. Considering that many experiments have suggested that β-1,4-galactosyltransferase I (β-1,4-GalT-I) and -V play significant roles in inflammation and the nervous system, in the present study we used Western blot analysis to study the effect of PQQ on the expression of β-1,4-GalT-I and -V. We found apparent expression upregulation of β-1,4-GalT-I and -V after PQQ was systemically administered. Lectin-fluorescent staining with RCA-I also revealed that PQQ contributed to expression upregulation of the galactosidase β-1 (Gal β-1), 4-galactosyltransferase N-acylsphingosine (4-GlcNAc) group in microglia and neurons of the cortex and hippocampal CA2 region. In summary, our experiment established that PQQ may play an important role in recovery post-TBI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22040225      PMCID: PMC3303106          DOI: 10.1089/neu.2011.1882

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  37 in total

1.  Expression change of beta-1,4 galactosyltransferase I, V mRNAs and Galbeta1,4GlcNAc group in rat sciatic nerve after crush.

Authors:  Meijuan Yan; Chun Cheng; Xiaoyi Shao; Ji Qian; Aiguo Shen; Chunlin Xia; Chun Xia
Journal:  J Mol Histol       Date:  2008-03-05       Impact factor: 2.611

2.  Effects of pyrroloquinoline quinone on glutamate-induced production of reactive oxygen species in neurons.

Authors:  J M Scanlon; E Aizenman; I J Reynolds
Journal:  Eur J Pharmacol       Date:  1997-05-12       Impact factor: 4.432

Review 3.  Beta-1,4-galactosylation of N-glycans is a complex process.

Authors:  K Furukawa; T Sato
Journal:  Biochim Biophys Acta       Date:  1999-12-06

4.  Pyrroloquinoline quinone (PQQ) decreases myocardial infarct size and improves cardiac function in rat models of ischemia and ischemia/reperfusion.

Authors:  Bo-Qing Zhu; Hui-Zhong Zhou; John R Teerlink; Joel S Karliner
Journal:  Cardiovasc Drugs Ther       Date:  2004-11       Impact factor: 3.727

5.  A novel coenzyme from bacterial primary alcohol dehydrogenases.

Authors:  S A Salisbury; H S Forrest; W B Cruse; O Kennard
Journal:  Nature       Date:  1979-08-30       Impact factor: 49.962

6.  New biological properties of pyrroloquinoline quinone and its related compounds: inhibition of chemiluminescence, lipid peroxidation and rat paw edema.

Authors:  Y Hamagishi; S Murata; H Kamei; T Oki; O Adachi; M Ameyama
Journal:  J Pharmacol Exp Ther       Date:  1990-12       Impact factor: 4.030

Review 7.  Is the antioxidant, anti-inflammatory putative new vitamin, PQQ, involved with nitric oxide in bone metabolism?

Authors:  P M Gallop; M A Paz; R Flückiger; E Henson
Journal:  Connect Tissue Res       Date:  1993       Impact factor: 3.417

8.  The inhibitory effect of pyrroloquinoline quinone on the amyloid formation and cytotoxicity of truncated alpha-synuclein.

Authors:  Jihoon Kim; Ryuichi Harada; Masaki Kobayashi; Natsuki Kobayashi; Koji Sode
Journal:  Mol Neurodegener       Date:  2010-05-20       Impact factor: 14.195

9.  The protective effect of pyrroloquinoline quinone and its derivatives against carbon tetrachloride-induced liver injury of rats.

Authors:  T Tsuchida; T Yasuyama; K Higuchi; A Watanabe; T Urakami; T Akaike; K Sato; H Maeda
Journal:  J Gastroenterol Hepatol       Date:  1993 Jul-Aug       Impact factor: 4.029

10.  Expression of beta-1,4-galactosyltransferase II and V in rat injured sciatic nerves.

Authors:  Aiguo Shen; Hanzhou Wang; Yong Zhang; Jun Yan; Dan Zhu; Jianxin Gu
Journal:  Neurosci Lett       Date:  2002-07-12       Impact factor: 3.046

View more
  10 in total

1.  Protective Effect of Pyrroloquinoline Quinone (PQQ) in Rat Model of Intracerebral Hemorrhage.

Authors:  Hongjian Lu; Jiabing Shen; Xinjian Song; Jianbin Ge; Rixin Cai; Aihua Dai; Zhongli Jiang
Journal:  Cell Mol Neurobiol       Date:  2015-03-29       Impact factor: 5.046

2.  Pyrroloquinoline Quinone Slows Down the Progression of Osteoarthritis by Inhibiting Nitric Oxide Production and Metalloproteinase Synthesis.

Authors:  Ran Tao; Shitao Wang; Xiaopeng Xia; Youhua Wang; Yi Cao; Yuejiao Huang; Xinbao Xu; Zhongbing Liu; Peichao Liu; Xiaohang Tang; Chun Liu; Gan Shen; Dongmei Zhang
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

3.  Pyrroloquinoline quinone (PQQ) protects mitochondrial function of HEI-OC1 cells under premature senescence.

Authors:  Ying Gao; Teru Kamogashira; Chisato Fujimoto; Shinichi Iwasaki; Tatsuya Yamasoba
Journal:  NPJ Aging       Date:  2022-04-19

4.  Pyrroloquinoline quinine protects rat brain cortex against acute glutamate-induced neurotoxicity.

Authors:  Qi Zhang; Mei Ding; Zheng Cao; Jingjing Zhang; Fei Ding; Kaifu Ke
Journal:  Neurochem Res       Date:  2013-05-18       Impact factor: 3.996

Review 5.  Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury.

Authors:  Clifford L Eastman; Raimondo D'Ambrosio; Thota Ganesh
Journal:  Neuropharmacology       Date:  2019-12-06       Impact factor: 5.250

Review 6.  The Controlled Cortical Impact Model: Applications, Considerations for Researchers, and Future Directions.

Authors:  Nicole D Osier; C Edward Dixon
Journal:  Front Neurol       Date:  2016-08-17       Impact factor: 4.003

7.  Beneficial effects of a pyrroloquinolinequinone-containing dietary formulation on motor deficiency, cognitive decline and mitochondrial dysfunction in a mouse model of Alzheimer's disease.

Authors:  Darrell Sawmiller; Song Li; Takashi Mori; Ahsan Habib; David Rongo; Vedad Delic; Patrick C Bradshaw; R Douglas Shytle; Cyndy Sanberg; Paula Bickford; Jun Tan
Journal:  Heliyon       Date:  2017-04-04

8.  Improving retinal mitochondrial function as a treatment for age-related macular degeneration.

Authors:  Mara C Ebeling; Jorge R Polanco; Jun Qu; Chengjian Tu; Sandra R Montezuma; Deborah A Ferrington
Journal:  Redox Biol       Date:  2020-05-18       Impact factor: 11.799

Review 9.  Pyrroloquinoline-Quinone Is More Than an Antioxidant: A Vitamin-like Accessory Factor Important in Health and Disease Prevention.

Authors:  Karen R Jonscher; Winyoo Chowanadisai; Robert B Rucker
Journal:  Biomolecules       Date:  2021-09-30

10.  Nacre-inspired magnetically oriented micro-cellulose fibres/nano-hydroxyapatite/chitosan layered scaffold enhances pro-osteogenesis and angiogenesis.

Authors:  Yu-Wei Ge; Min Chu; Zi-Yang Zhu; Qin-Fei Ke; Ya-Ping Guo; Chang-Qing Zhang; Wei-Tao Jia
Journal:  Mater Today Bio       Date:  2022-09-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.